FDA Inspection 1163048 - Assertio Therapeutics, Inc. - February 22, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Assertio Therapeutics, Inc., with an inspection on February 22, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Assertio Therapeutics, Inc.
Inspection Date: February 22, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 6ff5a73e-6ea7-4df8-8a9b-76b3a31de3fe